Estudio farmacoeconómico del tratamiento de la hipertensión arterial en pacientes del hospital San Juan de Riobamba.

Abstract

The main objective of this research study was to perform a pharmacoeconomic study for the treatment of arterial hypertension, in patients of the Hospital San Juan de Riobamba in the period July - October 2023. Arterial hypertension is a serious health problem in Ecuador and Latin America affecting a large part of the adult population and contributing to the mortality rate. This disease has significant medical, social and economic consequences, especially for those patients with limited resources, which can lead to additional complications and difficulties to have a good quality of life. The methodology used had a mixed approach, with a non-experimental design because no variables were manipulated, its temporal scope is cross-sectional since only one sample was taken in a given period of time and it is a field and documentary research developed in the San Juan Hospital, since clinical histories and prescriptions provided within the same were reviewed to obtain information on the schemes and costs of treatments used. Through this methodology, it was determined that most of the patients diagnosed with arterial hypertension have controlled levels, the prescription made was according to their needs, and these treatments coincide with those established in the pharmacotherapeutic guidelines of Ecuador, it is also mentioned that the cost may vary according to some factors such as the brand of medication, dosage and as monotherapy or combined therapy. Therefore, it is concluded that, in order to choose the best alternative, it should be taken into account that it is economical, safe, beneficial and effective. In the case of monotherapy enalapril 20 mg and losartan 100 mg, for combined therapy furosemide 20 mg + spiroactone 25mg and losartan 100mg + chlorthalidone 50 mg.